Provided by Tiger Trade Technology Pte. Ltd.

Adicet Bio, Inc.

7.03
+0.59009.16%
Post-market: 6.88-0.1500-2.13%17:14 EST
Volume:226.24K
Turnover:1.55M
Market Cap:67.34M
PE:-0.35
High:7.03
Open:6.55
Low:6.55
Close:6.44
52wk High:17.44
52wk Low:6.41
Shares:9.58M
Float Shares:8.25M
Volume Ratio:1.39
T/O Rate:2.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-20.1770
EPS(LYR):-21.3273
ROE:-71.73%
ROA:-39.13%
PB:0.62
PE(LYR):-0.33

Loading ...

Adicet Bio CEO to Present at Guggenheim Emerging Outlook Biotech Summit

Reuters
·
Jan 30

Adicet Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 21

Refile-Adicet Bio, Inc. : H.c. Wainwright Adjusts Target Price to $50 From $9 to Reflect Reverse Stock Split (Clarifies PT Is Split Adjusted)

THOMSON REUTERS
·
Jan 21

Adicet Bio price target adjusted to $50 from $9 at H.C. Wainwright

TIPRANKS
·
Jan 21

Adicet Bio, Inc. : H.c. Wainwright Raises Target Price to $50 From $9

THOMSON REUTERS
·
Jan 21

Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones

THOMSON REUTERS
·
Jan 07

Adicet Bio Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jan 06

Adicet Bio Announces One-for-16 Reverse Stock Split

Reuters
·
Dec 26, 2025

Adicet Bio Inc. Held Special Shareholder Meeting

Reuters
·
Dec 20, 2025

Adicet Bio Grants Inducement Stock Options to New Hire

Reuters
·
Nov 29, 2025

Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Nov 29, 2025

Adicet Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 07, 2025

Adicet Bio Q3 EPS $(0.29) Beats $(0.30) Estimate

Benzinga
·
Nov 06, 2025

Adicet Bio Reports Positive Preliminary Phase 1 Data and Extends Cash Runway Into 2027

Reuters
·
Nov 06, 2025

Gene therapy firm MaxCyte misses Q3 revenue estimates

Reuters
·
Nov 05, 2025

BRIEF-Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 01, 2025

Adicet Bio Grants Stock Options to New Hires Under Inducement Plan

Reuters
·
Nov 01, 2025

Adicet Bio Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
Oct 31, 2025

Canaccord Genuity Remains a Buy on Adicet Bio (ACET)

TIPRANKS
·
Oct 17, 2025

Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of Adi-001 in Treatment-Refractory Rheumatoid Arthritis (Ra)

THOMSON REUTERS
·
Oct 16, 2025